How safe is aggressive statin therapy? - sprookjes - yvandenbroek - TriplyDB

How safe is aggressive statin therapy?

How safe is aggressive statin therapy?

http://www.wikidata.org/entity/Q36587418

about

Collagen with simvastatin promotes cell metabolism in osteoblast-like SaOS-2 cells.The safety of rosuvastatin: effects on renal and hepatic function.Safety of statins.Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis.

P2860

Q36307541-70512002-3CC4-46E4-B722-E62FF6D44355 Q36945023-9C2C508F-6BD2-4999-8D15-76FFB4B3105D Q37095088-5FB29AAA-A32A-4343-AF65-6D4254C38475 Q37223505-F453C29C-AC40-4ABB-BFA8-3713CB30B0C9

P2860

How safe is aggressive statin therapy?

http://www.wikidata.org/entity/Q36587418

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

How safe is aggressive statin therapy?

@ast

How safe is aggressive statin therapy?

@en

type

label

How safe is aggressive statin therapy?

@ast

How safe is aggressive statin therapy?

@en

prefLabel

How safe is aggressive statin therapy?

@ast

How safe is aggressive statin therapy?

@en

P1433

Q36587418-6D4B3407-BFDC-4F25-AE2D-F396D1D32F31

P1476

Q36587418-3E77DCE5-E377-4B49-9B39-CA4726D802A4

P2093

Q36587418-2C3FC0FF-C704-48F0-9324-77302F78501F

P2860

Q36587418-05798CAA-97C9-40D9-A76D-1ECCC7038ECA

Q36587418-1AC5BB24-8597-4AFC-A22D-73036F39617A

Q36587418-1C1E744A-6AF2-4053-9229-12A2636FCDA6

Q36587418-1E84DAB5-9947-4353-B387-806AE40FCE88

Q36587418-3CFDF75E-FE77-490A-B57A-BF209E566DB2

Q36587418-3E3132E4-6715-47A9-A8DD-B8ED82DD02C2

Q36587418-4513CC1B-6FF4-4F70-AD3D-F664498F2DF6

Q36587418-4AB08E20-3DA8-47C0-A2F4-0DD678EF65A5

Q36587418-6AFC927F-7E0C-4100-96FA-E47A1106C32C

Q36587418-757F5F82-4933-469A-A36E-A0FA70A0B557

P304

Q36587418-7EE54D08-66B4-4DE8-B5E9-94E1E2EA52D3

P31

Q36587418-CC9B9E8D-EFB4-4F1E-845A-AF932B3A66B6

P356

Q36587418-3F70F78A-409F-49D7-85D0-31C91324AEC8

P433

Q36587418-54476825-03B5-4778-8224-B5E29B8FB275

P478

Q36587418-6A2B0357-0A00-4D71-8ADC-353CD4E3B779

P577

Q36587418-F76F83C2-D928-49C3-8EC3-CE9D08E090B6

P698

Q36587418-7DC0021E-37AF-42C6-A95D-899F47D50FBF

P921

Q36587418-49F49B80-CA14-4475-BD8F-5035E4160BB8

P356

J.0889-7204.2006.05616.X

P1433

Progress in Cardiovascular Nursing

P1476

How safe is aggressive statin therapy?

@en

P2093

Robert M Guthrie

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

Comparative tolerability of the HMG-CoA reductase inhibitors.

FDA adverse event reports on statin-associated rhabdomyolysis.

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

Safety of statins: focus on clinical pharmacokinetics and drug interactions.

Update on statins: 2003.

Rhabdomyolysis and HMG-CoA reductase inhibitors.

P304

140-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.0889-7204.2006.05616.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16957460

http://www.w3.org/2001/XMLSchema#string

P921